In the current, complex healthcare environment, key to the successful launch of any new pharmaceutical product or device is the ability to develop and implement an effective market access strategy.
With over 18 years of market access experience in a large pharmaceutical company, Jane Griffin has been responsible for the market access strategy and its effective delivery for multiple products. A proven track record of successful health technology appraisal submission and past membership of HTA bodies (AWMSG and New Drugs Committee of SMC) means that Jane really understands how these bodies operate and think.
Jane Griffin Associates has been formed to ensure that pharmaceutical, biotechnology and device companies achieve the full potential of their products and investment and that patients can have access to medicines and devices they might otherwise have been denied.
- Bespoke, market access solutions for individual products
- Extensive contacts in pharmaceutical industry and market access
- Proven track record with UK and Ireland HTA bodies
- Flexible approach according to company and investor needs